The methods of social network analysis were used to study the current status of Pueraria products in China. Method:The information of Puerariafunctional food and drug were retrieved by the China Food and Drug Administration (CFDA), and log in to China Knowledge Network to sort out the literature with “Gegen” as the Keywordor “title”. Thencounting the number of products approved, the iconic ingredients, product dosage forms and other information approved1997-2018 in the year, combined with Bibexcel analysis software to extract and organize the main compatibility of Dendrobium candidum health food, using NetDraw in Ucinet 6.0 software to build a visual network. Results: 1. It was found that the number of registered pueraria health products was 549 between 1997 and 2018, and the number of approved puerarin drugs was 231. 2. The health function of pueraria health food mainly protects liver damage (73), lowers blood sugar (106), lowers blood fat (91), enhances immunity (68), etc.; the main pharmacological action of puerarin is mainly diabetes (19), liver damage (9) 3. Pueraria health food dosage forms are mainly capsules (63.37%) and tablets (13.97%) granules (5.5.1%). The medicines are mainly injections (68.45%) and tablets (22.46%). 4. The most common compatibility of the products containing Dendrobium candidum is the combination of Radix Puerariae and Radix Astragali. 5. The main active ingredients of Pueraria-containing products are flavonoids and crude polysaccharides. Conclusion: At present, the Pueraria product market is large, but there is still a large room for development. Pueraria health food needs to focus on the development of new health functions. The dosage form needs to be developed towards food and the form needs to be innovative. Pueraria medicine still needs to pay attention to basic pharmacological research and lay a foundation for new pharmacological effects.
北京大学生命科学学院启东产业创新基金（SLS-Qidong Innovation Fund）